Icon

CAMZYOS (nda214998)- (2.5MG,5MG,10MG,15MG)

MAVACAMTEN BRISTOL
2.5MG,5MG,10MG,15MG
No No
2034-Jun-19 2027-Apr-28
None None
None No
CAMZYOS is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
0 0 0
Total Other Developers 5
Drugs with Suitability No
2.5MG ** ** - - -
5MG ** ** - - -
10MG ** ** - - -
15MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.